Skip to main content
. 2018 May 23;16(6):179. doi: 10.3390/md16060179

Figure 1.

Figure 1

Overview of regulative parameters of nanoparticles use (biomaterials, metal and metal-oxides, carbon-based) for devising an optimized nanoformulation for clinical drug applications.